Navigation Links
US Oncology Research Affiliated Physicians to Present at 2011 ASCO Annual Meeting
Date:5/26/2011

P, Texas Oncology, will be speaking during an education session on the management of unique subsets of patients with renal cell cancer. This session takes place on Sunday, June 5 in Hall D2 from 11:30 AM – 12:45 PM.

US Oncology Research has a long history of bringing innovative and successful agents to market. To date, US Oncology Research has played a role in the development of 43 FDA approved cancer fighting therapies.

Other presentations that McKesson Specialty Care Solutions | US Oncology affiliated investigators are part of include:

Oral Presentations:Thomas Cartwright, MD, Ocala Oncology CenterSaturday, June 4, 2:45 PM – 3:00 PM, Hall D1


  • A multinational, randomized phase III study of bevacizumab (Bev) with FOLFOX4 or XELOX versus FOLFOX4 alone as adjuvant treatment for colon cancer (CC): Subgroup analyses from the AVANT trial.Thomas E. Hutson, DO, PharmD, FACP, Texas OncologySaturday, June 4, 4:00 PM – 4:15 PM, Arie Crown Theater


  • BRIM-2: An open-label, multicenter phase II study of RG7204 (PLX4032) in previously treated patients with BRAF V600E mutation-positive metastatic melanoma.Michael Teneriello, MD, FACOG, Texas OncologySaturday, June 4, 4:15 PM - 4:30 PM, E354a

  • OCEANS: A randomized, double-blinded, placebo-controlled, phase III trial of chemotherapy with or without bevacizumab (BEV) in patients with platinum-sensitive recurrent epithelial ovarian (EOC), primary peritoneal (PPC), or fallopian tube cancer (FTC).Jerome Goldschmidt, MD, Blue Ridge Cancer CareSunday, June 5, 10:00 AM - 10:15 AM, Hall D1


  • Final efficacy results from OAM4558g, a randomized Phase II study evaluating MetMAb or placebo in combination with Erlotinib in advanced NSCLC.Daniel D. Von
    '/>"/>


  • SOURCE US Oncology, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related medicine technology :

    1. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
    2. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
    3. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
    4. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
    5. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
    6. University of Pennsylvania School of Medicine Study Shows Significant Differences in English- and Spanish-speakers Use of Oncology Websites
    7. Statement by US Oncology on FDA Label on Erythropoiesis Stimulating Agents (ESAs)
    8. Pharsight Uses FDA Disease Model to Support Oncology Drug Development
    9. US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium
    10. IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology
    11. Preliminary PI-88 Phase 2 Prostate Cancer Results to be Presented at the American Society for Clinical Oncology (ASCO) 2008 Genitourinary Cancer Symposium
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/24/2015)... -- Boston Scientific Corporation (NYSE: BSX ) is scheduled ... Healthcare Conference on May 6 in Boston ... and chief financial officer, and Susie Lisa , vice ... answer session regarding the company with the host analyst at ... the presentation and question and answer session will be available ...
    (Date:4/24/2015)... 2015  Novartis Pharmaceuticals Corporation (NPC) has been named the ... row on the annual DiversityInc Top 50 Companies for Diversity ... Companies for Diversity on April 23 at an awards ceremony ... ranked second on the DiversityInc Top 10 Companies for Recruitment ... Resource Groups list. David Epstein , ...
    (Date:4/24/2015)... 2015 /CNW/ - T-Bird Pharma Inc. (TSXV:TPI) ("T-Bird" or ... quality medical marijuana products and a licensed producer ("LP") ... Regulations ( Canada ) ("MMPR"), is pleased ... shareholders, has closed the transaction announced on March 11, ... (the "Escrow Transfer") a total of 20,156,790 common shares ...
    Breaking Medicine Technology:Boston Scientific To Participate In The Deutsche Bank 40th Annual Healthcare Conference 2Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 2Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 3Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 4T-Bird Pharma Inc. Announces Closing of Transaction with Medna Biosciences 2T-Bird Pharma Inc. Announces Closing of Transaction with Medna Biosciences 3
    ... 2011 On Wednesday, April 27 at 11 a.m., ... Langevin, Governor Lincoln Chafee, Lieutenant Governor Elizabeth H. Roberts, ... at its headquarters at 211 Circuit Drive in North ... Peter F. Kilmartin will tour Dominion,s laboratory at 1 ...
    ... JACKSON, Wis., April 25, 2011 Wisconsin Pharmacal Company, ... market recall of Triad Povidone Iodine Prep Pads, manufactured ... names including Triad. The Triad Povidone Iodine Prep Pads ... distributed by Wisconsin Pharmacal Company. In the interest of ...
    Cached Medicine Technology:Dominion Diagnostics Celebrates National Medical Laboratory Professionals Week with Rhode Island Elected Officials 2Important Information for Atwater Carey First Aid Kit Consumers Regarding Triad Group's Povidone Iodine Prep Pads 2
    (Date:4/24/2015)... York, NY (PRWEB) April 24, 2015 ... sober living residence in Westchester County. Just 35 miles ... help transition individuals back into everyday life while recovering ... Thursday, May 7, 2015, will allow therapists, doctors and ... areas and learn more about the opportunities offered by ...
    (Date:4/24/2015)... Foothill Ranch, California (PRWEB) April 24, 2015 ... that has a wide range of capabilities and services ... etc. , Ryadon's Quantity Discount Program will be ... ) as follows: , Order 4-19: Receive 10% discount ... Can Benefit by Using the Drawer Slides Products, ...
    (Date:4/24/2015)... York (PRWEB) April 24, 2015 ... move forward in the federal multidistrict litigation underway ... According to court documents, the parties involved in ... April 16th detailing, among other things, preparation for ... that counsel for both plaintiffs and defendants have ...
    (Date:4/24/2015)... The first step to transforming one’s life ... meditation and yoga teacher Stine Koppernæs, meditation and changing ... that allow her to experience more peace and freedom ... teacher since 2006, and through the years she has ... , “I love sharing this way of finding true, ...
    (Date:4/24/2015)... Anchor Health Administrators (Anchor), specialists in Long-Term Care ... exclusive agreement with LTC Solutions for All LLC (SFA) ... , Anchor has more than 18 years of experience ... and is currently the designated advocate for the American ... member benefit. , “I am very pleased to be ...
    Breaking Medicine News(10 mins):Health News:Constellations Recovery Opens The First Luxury Sober Living Residence in Westchester New York 2Health News:Constellations Recovery Opens The First Luxury Sober Living Residence in Westchester New York 3Health News:Ryadon Inc. Offers Quantity Drawer Slide Discount Program Nationwide in May 2015 2Health News:Ryadon Inc. Offers Quantity Drawer Slide Discount Program Nationwide in May 2015 3Health News:Federal Lipitor Lawsuits Progress, as New Status Report Details Preparation for Upcoming Bellwether Trials 2Health News:Federal Lipitor Lawsuits Progress, as New Status Report Details Preparation for Upcoming Bellwether Trials 3
    ... Millions of Americans have an undiagnosed artery disorder that can ... study reveals. The disorder is fibromuscular dysplasia, an accumulation ... narrow. The condition can occur in any artery but occurs ... to 4 percent of Americans. If untreated, fibromuscular dysplasia ...
    ... request that the journals Science and ... modified H5N1 virus because of biosecurity concerns does not ... They caution, however, that a fair, transparent process ... on disseminating scientific information., Writing in Science , ...
    ... are not as fit as earlier generations, and even the ... of inactivity could have a major long-term health impact. ... on a survey of Norwegian schoolchildren,s performance in the 3 ... Leif Inge Tjelta and Sindre Dyrstad at the University of ...
    ... , ROCHESTER, Minn. -- Results of two studies suggest ... developed in a collaboration between Mayo Clinic and Exact ... significantly more sensitive than other noninvasive tests at detecting ... important implications for clinicians and tens of thousands of ...
    ... of new federal legislation, electronic health records (EHRs) are ... nurses the frontline providers of care. In the ... University of Pennsylvania School of Nursing determined that nurses ... care and better health outcomes for patients than nurses ...
    ... investigational drug called regorafenib slowed the progression of tumors and ... , an international phase III clinical trial found. The findings ... the American Society of Clinical Oncology in San Francisco ... , principal investigator of the trial in the United States. ...
    Cached Medicine News:Health News:Narrowed Artery Condition Often Goes Undiagnosed: Study 2Health News:Balancing scientific freedom and national security 2Health News:Balancing scientific freedom and national security 3Health News:Sitting it out 2Health News:Sitting it out 3Health News:New test offers greater accuracy in early detection of colorectal cancer 2Health News:New test offers greater accuracy in early detection of colorectal cancer 3Health News:Better together - The RN and the EHR 2Health News:Drug improves survival of colorectal cancer patients, trial results show 2
    ... Super Pulse sealed CO2 surgical lasers offer ... the experience and support services of a ... laser experience. All settings are available at ... MD Super Pulse surgical lasers are compatible ...
    ... and targeting make treatment quick and effective ... cone angle, adjustable offset and variable pulse ... on the most modern IOLs without damage ... optics ensure low energy plasma formation with ...
    ... Pentacam images the anterior segment of the ... This rotating process supplies pictures in three ... measured very precisely because of this rotational ... than two seconds and minute eye movements ...
    ... SP-2000P Non -Contact Specular Microscope is ... and versatility in non-contact specular microscopy. ... Topcon's Imagenet system. Dual measurement system: ... 3D auto alignment and auto capture ...
    Medicine Products: